In giving final approval to the $158 million settlement with Texas over illegal promotion of Risperdal, Judge John Dietz denied Johnson &Johnson’s request to halve whistleblower Allen Jones’ share of the award. Jones, who lost his job as an investigator for Pennsylvania’s Office of the Inspector General when he brought attention to Medicaid fraud which has resulted in dozens of resolved and pending lawsuits, worried that J&J’s effort to limit his award would discourage other whistleblowers and law firms from filing such cases. “The number is not what it was originally about,” Jones said.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.